Announced Fri, 26 Jun · 17:05 IST
Trading window closure for Q1 FY2026-27 ending June 30, 2026
Compliance View source PDF
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.9%1-day move
₹961.00
prior close
₹971.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.4-2.9-3.4-4.2+0.9+1.1+1.7-0.2-3.1+4.4+8.9———
Up moveDown movePending
AI summary
Orchid Pharma Ltd has informed the exchanges that the trading window for insiders, including directors and key managerial personnel, will remain closed for the first quarter of financial year 2026-27, ending on June 30, 2026. This is a routine compliance measure under SEBI insider trading regulations, typically enforced ahead of quarterly financial results to prevent insider trading.
Likely market impact
Routine compliance announcement. No direct impact on shareholders or stock price. Insiders barred from trading until results are announced.